CompletedNCT00483106
Methylphenidate for ADHD in children
About this title
Read the official source — NCT00483106Medication studyAges 6–12Canada
Understand this study
Who was this study for?
Listed age limits: 6 years to 12 years.
- Listed locations
- MontrealSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Study information
Study start dateStarted: November 1999
- Recruitment status
- Completed
- Enrollment listed in the registry
- 885
- Sponsor
- McGill University
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- Canada
- Age range
- From 6 Years to 12 Years
- Official registry ID
- NCT00483106
- Official title
Show the full official title
Clinical and Pharmacogenetic Study of Attention Deficit With Hyperactivity Disorder (ADHD)
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Montreal
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is McGill University, a university.
Did this study involve medication?
Yes. The study involved medication, including Ritalin and Placebo.
Who was this study for?
Listed age limits: 6 years to 12 years.
